SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-192691
Filing Date
2020-07-14
Accepted
2020-07-14 17:20:02
Documents
13
Period of Report
2020-07-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d948092d8k.htm   iXBRL 8-K 45101
2 EX-10.1 d948092dex101.htm EX-10.1 114506
  Complete submission text file 0001193125-20-192691.txt   311941

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amrn-20200713.xsd EX-101.SCH 3076
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20200713_lab.xml EX-101.LAB 18840
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20200713_pre.xml EX-101.PRE 11843
6 EXTRACTED XBRL INSTANCE DOCUMENT d948092d8k_htm.xml XML 3927
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 201027722
SIC: 2834 Pharmaceutical Preparations